Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116,928Revenue (TTM) $M37,728Net Margin (%)13.6Altman Z-Score2.0
Enterprise Value $M130,780EPS (TTM) $2.0Operating Margin %18.8Piotroski F-Score7
P/E(ttm)24.2Beneish M-Score-2.6Pre-tax Margin (%)16.4Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %-1.6Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-4.2Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow18.6y-y EBITDA Growth Rate %-4.3ROA % (ttm)4.6Higher Current Ratio y-yY
Dividend Yield %3.5PEG--ROE % (ttm)8.3Less Shares Outstanding y-yY
Payout Ratio %86.0Shares Outstanding M2,584ROIC % (ttm)7.6Gross Margin Increase y-yY

Gurus Latest Trades with SNY

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SNY is held by these investors:



SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-50.62view
Sanofi10% Owner 2015-01-26Buy647,448$95-50.62view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-49.65view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-29.86view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67511.6view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (aliro Apr 25 2017 
    Regeneron and Sanofi Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (aliro Apr 25 2017 
    Sanofi Receives FDA Approval of Thymoglobulin® for the Prevention of Acute Kidney Transplant Reject Apr 24 2017 
    Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients Apr 24 2017 
    Can Pluristem Therapeutics Corner the Acute Radiation Syndrome Market? Apr 11 2017 
    Sanofi Launches First-Ever ACT® Kids Toothpaste in the U.S. Apr 03 2017 
    Switching to Sanofi's Toujeo® Showed Significant Reductions in Blood Sugar and Significantly Lower Apr 02 2017 
    Award-Winning International Fund Manager David Herro Picks 3 Stocks Mar 03 2017 
    While Big Diabetes Stagnates, Smaller Companies Are Moving Faster Than Ever Feb 09 2017 
    David Herro's Oakmark International Fund Fourth Quarter Letter Jan 11 2017 

    More From Other Websites
    Amgen's Q1 Results Highlight the Need for an Acquisition Apr 27 2017
    Dupixent Expected to Be a Solid Addition to Regeneron’s Portfolio Apr 27 2017
    One in 7 people in Nevada is living with diabetes, and the state is now pushing a new approach to... Apr 26 2017
    Amgen Trips Amid Rivals: Sales Miss By $100 Million, But Earnings Top Apr 26 2017
    Will Amgen's Rivals Pop On Its Cholesterol-Busting Drug? Apr 26 2017
    Why Flexion Therapeutics Inc. Stock Is Tanking Apr 26 2017
    Moody's: Outlook for global pharmaceuticals industry stable on low earnings growth, new product... Apr 26 2017
    K-Mart to Sell Cheaper EpiPen Alternative Apr 25 2017
    New Data Suggest Positive Effects of Sanofi Genzyme’s Aubagio® (teriflunomide) on Cortical Gray... Apr 25 2017
    Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent®... Apr 25 2017
    New Investigational Data on Six-Year Efficacy of Sanofi Genzyme’s Lemtrada® (alemtuzumab) in... Apr 25 2017
    Regeneron and Sanofi Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent®... Apr 25 2017
    Mylan Tried to ‘Squelch’ EpiPen Rival, Sanofi Says in Lawsuit Apr 24 2017
    Sanofi Sues Mylan Over EpiPen Practices Apr 24 2017
    Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen Apr 24 2017
    Sanofi has filed an antitrust suit against Mylan alleging 'illegal conduct' to prevent EpiPen... Apr 24 2017
    Sanofi Receives FDA Approval of Thymoglobulin® for the Prevention of Acute Kidney Transplant... Apr 24 2017
    Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients... Apr 24 2017
    [$$] Sanofi plays down need for pharma deals Apr 23 2017
    Amgen Trumps Regeneron, Sanofi In Cholesterol Drug Sales Apr 21 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)